The September and October Edition of the Regulatory and Pharma news has been published. Highlights include:
- Efforts are amplified to ensure medical supply post brexit.
- MHRA to consult on EU exit no deal legislative proposals.
- HRA published a joint statement with the MHRA on seeking & documenting consent using electronic methods.